Characteristics of invasive pneumococcal disease in hospitalized children in Austria

European Journal of Pediatrics

Volumn 173, Issue 4, 2014, Pages 469-476

  Paulke Korinek, Maria ^a   Kollaritsch, Herwig ^a   Kundi, Michael ^a   Schmidle Loss, Birgit ^a   Zwazl, Ines ^a   Laaber, Brigitte ^a   Lakovits, Karin ^a   Vecsei, Andreas ^b   Wiedermann, Ursula ^a   Burgmann, Heinz ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

Antimicrobial resistance; Invasive pneumococcal disease; Serotypes; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; CEFIXIME; CEFPODOXIME; CEFTRIAXONE; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; PNEUMOCOCCUS VACCINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; AUSTRIA; CHILD; DISEASE SURVEILLANCE; HEARING IMPAIRMENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MOTOR DYSFUNCTION; NONHUMAN; PNEUMOCOCCAL INFECTION; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROTYPE; EPIDEMIOLOGY; FEMALE; HEALTH SURVEY; HOSPITALIZED CHILD; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; MALE; PNEUMOCOCCAL INFECTIONS; PRESCHOOL CHILD; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE;

ANTI-BACTERIAL AGENTS; AUSTRIA; CHILD; CHILD, HOSPITALIZED; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE;

EID: 84897027114     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-013-2193-2     Document Type: Article

References (24)

1. Bundesanstalt Statistik Österreich. STATcube - Statistische Datenbank von Statistik Austria. Wien: Bundesanstalt Statistik Österreich 2013. http://sdb.statistik.at/superwebguest/autoLoad.do, Accessed 24 Jan 2013
2. Chapman KE, Wilson D, Gorton R (2013) Serotype dynamics of invasive pneumococcal disease post-PCV7 and pre-PCV13 introduction in North East England. Epidemiol Infect 141:344-352
3. Committee on Infectious Diseases (2000) Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 106:362-366
4. Dagan R (2009) Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Infect 15:16-20
5. Ercibengoa M, Arostegi N, Marimon J, Alonso M, Perez-Trallero E (2012) Dynamics of pneumococcal nasopharyngeal carriage in healthy children attending a day care center in northern Spain. Influence of detection techniques on the results. BMC Infect Dis 12:69
6. Fitzwater SP, Chandran A, Santosham M, Johnson HL (2012) The worldwide impact of the seven-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 31:501-508
7. Ingels H, Rasmussen J, Andersen PH, Harboe ZB, Glismann S, Konradsen H, Hoffmann S, Valentiner-Branth P, Lambertsen L (2012) Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme. Vaccine 30:3944-3950
8. Isaacman DJ, McIntosh ED, Reinert RR (2010) Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis 14:e197-e209
9. Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, Thomas AR, Harrison LH, Bennett NM, Farley MM, Facklam RR, Jorgensen JH, Besser J, Zell ER, Schuchat A, Whitney CG (2006) Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 354:1455-1463
10. Liu C, Xiong X, Xu W, Sun J, Wang L, Li J (2013) Serotypes and patterns of antibiotic resistance in strains causing invasive pneumococcal disease in children less than 5 Years of Age. PLoS ONE 8:e54254
11. Magnus MC, Vestrheim DF, Nystad W, Haberg SE, Stigum H, London SJ, Bergsaker MA, Caugant DA, Aaberge IS, Nafstad P (2012) Decline in early childhood respiratory tract infections in the Norwegian mother and child cohort study after introduction of pneumococcal conjugate vaccination. Pediatr Infect Dis J 31:951-955
12. Nationales Impfgremium (2012) Impfplan 2012. vol 2012. Bundeministerium für Gesundheit. http://bmg.gv.at/home/Schwerpunkte/Praevention/Impfen/ Oesterreichischer-Impfplan; Accessed 22 Jul 2013
13. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T (2009) Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374:893-902
14. Österreichischer Sanitätsrat. Impfplan 2010. http://www.centralapo.at/impfplan10.pdf. Accessed 6 Feb 2013
15. Rendi-Wagner P, Georgopoulos A, Kundi M, Mutz I, Mattauch M, Nowak J, Mikolasek A, Vecsei A, Kollaritsch H (2004) Prospective surveillance of incidence, serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae among hospitalized children in Austria. J Antimicrob Chemother 53:826-831 (Pubitemid 38660286)
16. Rendi-Wagner P, Paulke-Korinek M, Kundi M, Burgmann H, Georgopoulos A, Vecsei A, Kollaritsch H (2009) National paediatric immunization programof high risk groups: no effect on the incidence of invasive pneumococcal diseases. Vaccine 27:3963-3968
17. Resti M, Moriondo M, Cortimiglia M, Indolfi G, Canessa C, Becciolini L, Bartolini E, de Benedictis FM, de Martino M, Azzari C (2010) Community-acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real-time polymerase chain reaction using blood samples. Clin Infect Dis 51:1042-1049
18. Rosen JB, Thomas AR, Lexau CA, Reingold A, Hadler JL, Harrison LH, Bennett NM, Schaffner W, Farley MM, Beall BW, Moore MR (2011) Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States. Clin Infect Dis 53:137-143
19. Saha SK, Darmstadt GL, Baqui AH, Hossain B, Islam M, Foster D, Al-Emran H, Naheed A, Arifeen SE, Luby SP, Santosham M, Crook D (2008) Identification of serotype in culture negative pneumococcal meningitis using sequential multiplex PCR: implication for surveillance and vaccine design. PLoS ONE 3:e3576
20. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. 2013; Version 3.0. http://www.eucast.org. Accessed 15 Jan 2013
21. van der Linden M, Weiss S, Falkenhorst G, Siedler A, Imohl M, von Kries R (2012) Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children. Vaccine 30:5880-5885
22. Vergison A, Reinert RR (2007) Streptococcus pneumoniae incidence in Western Europe. Lancet Infect Dis 7:240-242 (Pubitemid 46414071)
23. Weil-Olivier C, van der Linden M, de Schutter I, Dagan R, Mantovani L (2012) Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective. BMC Infect Dis 12:207
24. World Health Organization (2012) Pneumococcal vaccines WHO position paper - 2012. WER 14:129-144